Search results
Roche’s Columvi offers extended survival in Phase III DLBCL trial
Clinical Trials Arena via Yahoo Finance· 16 hours agoIt enrolled DLBCL patients who were previously treated with a minimum of one line of therapy and did...
Salute to saving a life: Local Air Force man answers the call for stem cell donation
Citrus Chronicle Online· 2 days agoAir Force, recently got the opportunity to save the life of a 26-year-old man who has leukemia, with...
Coping With Graft-Versus-Host-Disease
Verywell Health via Yahoo News· 6 days agoLearn how to cope with your graft-versus-host-disease day-to-day, including how to eat to reduce symptoms, exercise, manage finances, and find support.
'Cancer broke my back - now I do things to make me smile'
BBC News· 11 hours agoA woman with incurable cancer that broke her back said she had to "change her mindset" and now does...
The U.S. Army Is Founded On This Date In 1775 | Newsradio WTAM 1100
iHeartRadio· 4 days agoToday in 1775, the United States Army was founded. Today in 1777, The Continental Congress approved...
'General Hospital's John J. York Emotionally Talks Returning to Soap After Cancer Battle
ET Online via AOL· 10 hours agoGeneral Hospital star John J. York became emotional while discussing his battle with cancer and the...
Novel gene-editing therapy continues to show positive results in sickle cell patients
Medical Xpress· 3 days agoThis innovative treatment modifies a patient's own blood-formingstem cells to correct the mutation...
...STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or...
Morningstar· 2 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma – The study met ...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
United Press International via Yahoo News· 4 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks via Yahoo Finance· 13 hours agoEditas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies...